Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Evaluation of a drug checking service at a large scale electronic music festival in Portugal.

Valente H, Martins D, Carvalho H, Pires CV, Carvalho MC, Pinto M, Barratt MJ.

Int J Drug Policy. 2019 Aug 6;73:88-95. doi: 10.1016/j.drugpo.2019.07.007. [Epub ahead of print]

PMID:
31398488
2.

Study of Environmental Enteropathy and Malnutrition (SEEM) in Pakistan: protocols for biopsy based biomarker discovery and validation.

Iqbal NT, Syed S, Sadiq K, Khan MN, Iqbal J, Ma JZ, Umrani F, Ahmed S, Maier EA, Denson LA, Haberman Y, McNeal MM, Setchell KDR, Zhao X, Qureshi S, Shen L, Moskaluk CA, Liu TC, Yilmaz O, Brown DE, Barratt MJ, Kung VL, Gordon JI, Moore SR, Ali SA.

BMC Pediatr. 2019 Jul 22;19(1):247. doi: 10.1186/s12887-019-1564-x.

3.

A sparse covarying unit that describes healthy and impaired human gut microbiota development.

Raman AS, Gehrig JL, Venkatesh S, Chang HW, Hibberd MC, Subramanian S, Kang G, Bessong PO, Lima AAM, Kosek MN, Petri WA Jr, Rodionov DA, Arzamasov AA, Leyn SA, Osterman AL, Huq S, Mostafa I, Islam M, Mahfuz M, Haque R, Ahmed T, Barratt MJ, Gordon JI.

Science. 2019 Jul 12;365(6449). pii: eaau4735. doi: 10.1126/science.aau4735.

4.

Effects of microbiota-directed foods in gnotobiotic animals and undernourished children.

Gehrig JL, Venkatesh S, Chang HW, Hibberd MC, Kung VL, Cheng J, Chen RY, Subramanian S, Cowardin CA, Meier MF, O'Donnell D, Talcott M, Spears LD, Semenkovich CF, Henrissat B, Giannone RJ, Hettich RL, Ilkayeva O, Muehlbauer M, Newgard CB, Sawyer C, Head RD, Rodionov DA, Arzamasov AA, Leyn SA, Osterman AL, Hossain MI, Islam M, Choudhury N, Sarker SA, Huq S, Mahmud I, Mostafa I, Mahfuz M, Barratt MJ, Ahmed T, Gordon JI.

Science. 2019 Jul 12;365(6449). pii: eaau4732. doi: 10.1126/science.aau4732.

5.

Mechanisms by which sialylated milk oligosaccharides impact bone biology in a gnotobiotic mouse model of infant undernutrition.

Cowardin CA, Ahern PP, Kung VL, Hibberd MC, Cheng J, Guruge JL, Sundaresan V, Head RD, Barile D, Mills DA, Barratt MJ, Huq S, Ahmed T, Gordon JI.

Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11988-11996. doi: 10.1073/pnas.1821770116. Epub 2019 May 28.

6.

Should we smoke it for you as well? An ethnographic analysis of a drug cryptomarket environment.

Kowalski M, Hooker C, Barratt MJ.

Int J Drug Policy. 2019 May 1. pii: S0955-3959(19)30069-6. doi: 10.1016/j.drugpo.2019.03.011. [Epub ahead of print]

PMID:
31054880
7.

Prevalence of reagent test-kit use and perceptions of purity among ecstasy users in an electronic dance music scene in New York City.

Palamar JJ, Barratt MJ.

Drug Alcohol Rev. 2019 Jan;38(1):42-49. doi: 10.1111/dar.12882. Epub 2018 Dec 21.

PMID:
30575155
8.

#Drugsforsale: An exploration of the use of social media and encrypted messaging apps to supply and access drugs.

Moyle L, Childs A, Coomber R, Barratt MJ.

Int J Drug Policy. 2019 Jan;63:101-110. doi: 10.1016/j.drugpo.2018.08.005. Epub 2018 Dec 7.

PMID:
30530252
9.

Double dropping down under: Correlates of simultaneous consumption of two ecstasy pills in a sample of Australian outdoor music festival attendees.

Grigg J, Barratt MJ, Lenton S.

Drug Alcohol Rev. 2018 Nov;37(7):851-855. doi: 10.1111/dar.12843. Epub 2018 Jul 11.

PMID:
30392182
10.

Harm reduction strategies related to dosing and their relation to harms among festival attendees who use multiple drugs.

Fernández-Calderón F, Díaz-Batanero C, Barratt MJ, Palamar JJ.

Drug Alcohol Rev. 2019 Jan;38(1):57-67. doi: 10.1111/dar.12868. Epub 2018 Oct 9.

PMID:
30302851
11.

Growing practices and the use of potentially harmful chemical additives among a sample of small-scale cannabis growers in three countries.

Lenton S, Frank VA, Barratt MJ, Potter GR, Decorte T.

Drug Alcohol Depend. 2018 Nov 1;192:250-256. doi: 10.1016/j.drugalcdep.2018.07.040. Epub 2018 Sep 13.

PMID:
30292153
12.

Urine drug screening for early detection of unwitting use of fentanyl and its analogues among people who inject heroin in Sydney, Australia.

Barratt MJ, Latimer J, Jauncey M, Tay E, Nielsen S.

Drug Alcohol Rev. 2018 Nov;37(7):847-850. doi: 10.1111/dar.12864. Epub 2018 Oct 5.

PMID:
30289187
13.

Drug detection dogs at Australian outdoor music festivals: Deterrent, detection and iatrogenic effects.

Grigg J, Barratt MJ, Lenton S.

Int J Drug Policy. 2018 Oct;60:89-95. doi: 10.1016/j.drugpo.2018.08.002. Epub 2018 Aug 31.

PMID:
30176423
14.

Digital era drug surveillance: Quo vadis, Australia?

Raubenheimer JE, Barratt MJ.

Drug Alcohol Rev. 2018 Sep;37(6):693-696. doi: 10.1111/dar.12853. No abstract available.

PMID:
30175478
15.

Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.

Banister SD, Adams A, Kevin RC, Macdonald C, Glass M, Boyd R, Connor M, McGregor IS, Havel CM, Bright SJ, Vilamala MV, Lladanosa CG, Barratt MJ, Gerona RR.

Drug Test Anal. 2019 Feb;11(2):279-291. doi: 10.1002/dta.2491. Epub 2018 Oct 1.

PMID:
30151911
16.

Typology of new psychoactive substance use among the general Australian population.

Sutherland R, Peacock A, Roxburgh A, Barratt MJ, Burns L, Bruno R.

Drug Alcohol Depend. 2018 Jul 1;188:126-134. doi: 10.1016/j.drugalcdep.2018.03.034. Epub 2018 May 3.

PMID:
29775956
17.

The impact of drug policy liberalisation on willingness to seek help for problem drug use: A comparison of 20 countries.

Benfer I, Zahnow R, Barratt MJ, Maier L, Winstock A, Ferris J.

Int J Drug Policy. 2018 Jun;56:162-175. doi: 10.1016/j.drugpo.2018.03.032. Epub 2018 May 3.

PMID:
29731288
18.

Drug-related police encounters across the globe: How do they compare?

Hughes CE, Barratt MJ, Ferris JA, Maier LJ, Winstock AR.

Int J Drug Policy. 2018 Jun;56:197-207. doi: 10.1016/j.drugpo.2018.03.005. Epub 2018 Apr 24.

PMID:
29699837
19.

Do people with intersecting identities report more high-risk alcohol use and lifetime substance use?

Demant D, Oviedo-Trespalacios O, Carroll JA, Ferris JA, Maier L, Barratt MJ, Winstock AR.

Int J Public Health. 2018 Jun;63(5):621-630. doi: 10.1007/s00038-018-1095-5. Epub 2018 Mar 31.

PMID:
29605878
20.

Author Correction: Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey.

Lawn W, Hallak JE, Crippa JA, Dos Santos R, Porffy L, Barratt MJ, Ferris JA, Winstock AR, Morgan CJA.

Sci Rep. 2018 Mar 1;8(1):4059. doi: 10.1038/s41598-018-21666-6.

21.

Harms, benefits and the policing of cryptomarkets: a response to commentaries.

Aldridge J, Stevens A, Barratt MJ.

Addiction. 2018 May;113(5):802-804. doi: 10.1111/add.14169. Epub 2018 Feb 21. No abstract available.

PMID:
29468766
22.

Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey.

Lawn W, Hallak JE, Crippa JA, Dos Santos R, Porffy L, Barratt MJ, Ferris JA, Winstock AR, Morgan CJA.

Sci Rep. 2017 Nov 9;7(1):15201. doi: 10.1038/s41598-017-14700-6. Erratum in: Sci Rep. 2018 Mar 1;8(1):4059.

23.

Exploring mortality among drug treatment clients: The relationship between treatment type and mortality.

Lloyd B, Zahnow R, Barratt MJ, Best D, Lubman DI, Ferris J.

J Subst Abuse Treat. 2017 Nov;82:22-28. doi: 10.1016/j.jsat.2017.09.001. Epub 2017 Sep 5.

PMID:
29021111
24.

Moving on From Representativeness: Testing the Utility of the Global Drug Survey.

Barratt MJ, Ferris JA, Zahnow R, Palamar JJ, Maier LJ, Winstock AR.

Subst Abuse. 2017 Jun 30;11:1178221817716391. doi: 10.1177/1178221817716391. eCollection 2017.

25.

Synthetic Cannabinoid Use Among High School Seniors.

Palamar JJ, Barratt MJ, Coney L, Martins SS.

Pediatrics. 2017 Oct;140(4). pii: e20171330. doi: 10.1542/peds.2017-1330. Epub 2017 Sep 11.

26.

Bangladesh Environmental Enteric Dysfunction (BEED) study: protocol for a community-based intervention study to validate non-invasive biomarkers of environmental enteric dysfunction.

Mahfuz M, Das S, Mazumder RN, Masudur Rahman M, Haque R, Bhuiyan MMR, Akhter H, Sarker MSA, Mondal D, Muaz SSA, Karim ASMB, Borowitz SM, Moskaluk CA, Barratt MJ, Petri WA, Gordon JI, Ahmed T.

BMJ Open. 2017 Aug 11;7(8):e017768. doi: 10.1136/bmjopen-2017-017768.

27.

The Gut Microbiota, Food Science, and Human Nutrition: A Timely Marriage.

Barratt MJ, Lebrilla C, Shapiro HY, Gordon JI.

Cell Host Microbe. 2017 Aug 9;22(2):134-141. doi: 10.1016/j.chom.2017.07.006. Review.

28.

Will growth in cryptomarket drug buying increase the harms of illicit drugs?

Aldridge J, Stevens A, Barratt MJ.

Addiction. 2018 May;113(5):789-796. doi: 10.1111/add.13899. Epub 2017 Aug 2.

29.

Food and microbiota in the FDA regulatory framework.

Green JM, Barratt MJ, Kinch M, Gordon JI.

Science. 2017 Jul 7;357(6346):39-40. doi: 10.1126/science.aan0836. No abstract available.

30.

The detection and prevention of unintentional consumption of DOx and 25x-NBOMe at Portugal's Boom Festival.

Martins D, Barratt MJ, Pires CV, Carvalho H, Vilamala MV, Espinosa IF, Valente H.

Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2608. Epub 2017 Jun 21.

PMID:
28635119
31.

Pill testing or drug checking in Australia: Acceptability of service design features.

Barratt MJ, Bruno R, Ezard N, Ritter A.

Drug Alcohol Rev. 2018 Feb;37(2):226-236. doi: 10.1111/dar.12576. Epub 2017 Jun 20.

PMID:
28635057
32.

The utility of drug checking services as monitoring tools and more: A response to Pirona et al.

Giné CV, Vilamala MV, Measham F, Brunt TM, Bücheli A, Paulos C, Valente H, Martins D, Libois B, Tögel-Lins K, Jones G, Karden A, Barratt MJ.

Int J Drug Policy. 2017 Jul;45:46-47. doi: 10.1016/j.drugpo.2017.05.018. Epub 2017 Jun 2. No abstract available.

PMID:
28582668
33.

Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis.

Lamy FR, Daniulaityte R, Nahhas RW, Barratt MJ, Smith AG, Sheth A, Martins SS, Boyer EW, Carlson RG.

Int J Drug Policy. 2017 Jun;44:121-129. doi: 10.1016/j.drugpo.2017.05.007. Epub 2017 Jun 1.

34.

Genie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile.

Coney LD, Maier LJ, Ferris JA, Winstock AR, Barratt MJ.

Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2599. Epub 2017 May 18.

PMID:
28517366
35.

New psychoactive substances: Purchasing and supply patterns in Australia.

Sutherland R, Bruno R, Peacock A, Dietze P, Breen C, Burns L, Barratt MJ.

Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2577. Epub 2017 May 18.

PMID:
28517235
36.

The effects of micronutrient deficiencies on bacterial species from the human gut microbiota.

Hibberd MC, Wu M, Rodionov DA, Li X, Cheng J, Griffin NW, Barratt MJ, Giannone RJ, Hettich RL, Osterman AL, Gordon JI.

Sci Transl Med. 2017 May 17;9(390). pii: eaal4069. doi: 10.1126/scitranslmed.aal4069.

37.

Motivations for new psychoactive substance use among regular psychostimulant users in Australia.

Sutherland R, Bruno R, Peacock A, Lenton S, Matthews A, Salom C, Dietze P, Butler K, Burns L, Barratt MJ.

Int J Drug Policy. 2017 May;43:23-32. doi: 10.1016/j.drugpo.2016.12.021. Epub 2017 Feb 2.

PMID:
28161577
38.

Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis.

Anderson LS, Bell HG, Gilbert M, Davidson JE, Winter C, Barratt MJ, Win B, Painter JL, Menone C, Sayegh J, Dasgupta N.

JMIR Public Health Surveill. 2017 Feb 1;3(1):e6. doi: 10.2196/publichealth.6174.

39.

Commentary on Vrolijk et al. (2017): The paradox of the quality control problem.

Barratt MJ, Ritter A.

Addiction. 2017 Jan;112(1):101-102. doi: 10.1111/add.13611. No abstract available.

PMID:
27936508
40.

A critical examination of the definition of 'psychoactive effect' in Australian drug legislation.

Barratt MJ, Seear K, Lancaster K.

Int J Drug Policy. 2017 Feb;40:16-25. doi: 10.1016/j.drugpo.2016.10.002. Epub 2016 Nov 21.

PMID:
27884504
41.

Everything you always wanted to know about drug cryptomarkets* (*but were afraid to ask).

Barratt MJ, Aldridge J.

Int J Drug Policy. 2016 Sep;35:1-6. doi: 10.1016/j.drugpo.2016.07.005. Epub 2016 Jul 25. No abstract available.

PMID:
27523571
42.

Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States.

Palamar JJ, Barratt MJ, Ferris JA, Winstock AR.

Am J Addict. 2016 Aug;25(5):400-7. doi: 10.1111/ajad.12403. Epub 2016 Jul 15.

43.

Childhood undernutrition, the gut microbiota, and microbiota-directed therapeutics.

Blanton LV, Barratt MJ, Charbonneau MR, Ahmed T, Gordon JI.

Science. 2016 Jun 24;352(6293):1533. doi: 10.1126/science.aad9359. Review.

PMID:
27339978
44.

Safer scoring? Cryptomarkets, social supply and drug market violence.

Barratt MJ, Ferris JA, Winstock AR.

Int J Drug Policy. 2016 Sep;35:24-31. doi: 10.1016/j.drugpo.2016.04.019. Epub 2016 May 6.

PMID:
27241015
45.

Results of an international drug testing service for cryptomarket users.

Caudevilla F, Ventura M, Fornís I, Barratt MJ, Vidal C, Lladanosa CG, Quintana P, Muñoz A, Calzada N.

Int J Drug Policy. 2016 Sep;35:38-41. doi: 10.1016/j.drugpo.2016.04.017. Epub 2016 May 6.

PMID:
27239011
46.

'What if you live on top of a bakery and you like cakes?'-Drug use and harm trajectories before, during and after the emergence of Silk Road.

Barratt MJ, Lenton S, Maddox A, Allen M.

Int J Drug Policy. 2016 Sep;35:50-7. doi: 10.1016/j.drugpo.2016.04.006. Epub 2016 Apr 13.

PMID:
27157539
47.

Synthetic cannabinoids: undesirable alternatives to natural marijuana.

Palamar JJ, Barratt MJ.

Am J Drug Alcohol Abuse. 2016 Jul;42(4):371-3. doi: 10.3109/00952990.2016.1139584. Epub 2016 Apr 11. No abstract available.

48.

Drug checking to improve monitoring of new psychoactive substances in Australia.

Butterfield RJ, Barratt MJ, Ezard N, Day RO.

Med J Aust. 2016 Mar 7;204(4):144-5. No abstract available.

PMID:
26937663
49.

Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children.

Blanton LV, Charbonneau MR, Salih T, Barratt MJ, Venkatesh S, Ilkaveya O, Subramanian S, Manary MJ, Trehan I, Jorgensen JM, Fan YM, Henrissat B, Leyn SA, Rodionov DA, Osterman AL, Maleta KM, Newgard CB, Ashorn P, Dewey KG, Gordon JI.

Science. 2016 Feb 19;351(6275). pii: aad3311. doi: 10.1126/science.aad3311.

50.

Sialylated Milk Oligosaccharides Promote Microbiota-Dependent Growth in Models of Infant Undernutrition.

Charbonneau MR, O'Donnell D, Blanton LV, Totten SM, Davis JC, Barratt MJ, Cheng J, Guruge J, Talcott M, Bain JR, Muehlbauer MJ, Ilkayeva O, Wu C, Struckmeyer T, Barile D, Mangani C, Jorgensen J, Fan YM, Maleta K, Dewey KG, Ashorn P, Newgard CB, Lebrilla C, Mills DA, Gordon JI.

Cell. 2016 Feb 25;164(5):859-71. doi: 10.1016/j.cell.2016.01.024. Epub 2016 Feb 18.

Supplemental Content

Loading ...
Support Center